IDEAS home Printed from https://ideas.repec.org/a/abf/journl/v50y2023i5p42041-42046.html
   My bibliography  Save this article

Tolerability of Angiotensin Receptor Neprilysin Inhibitor (ARNI) with Two Classes of Beta-Blockers- A Real-world Retrospective Study in a Tertiary Hospital

Author

Listed:
  • Abdulaziz Alqadi

    (Department of Pharmacy, Security Forces Hospital, Saudi Arabia)

Abstract

Our study compares the use of ARNI plus Carvedilol or ARNI plus Bisoprolol in real-world settings to assess suboptimal ARNI use due to hypotension. A respective single-center study was performed in a tertiary hospital in the Riyadh region from 2017 to 2021. We studied individuals diagnosed with HFrEF who have started using ARNI drugs. First patients who were on ARNI plus Bisoprolol, while the second group included patients who were on ARNI plus Carvedilol. A descriptive analysis was conducted, and a chi-square test was used to assess the differences between categorical variables and outcomes. The statistically significant p-value was less than 0.05

Suggested Citation

  • Abdulaziz Alqadi, 2023. "Tolerability of Angiotensin Receptor Neprilysin Inhibitor (ARNI) with Two Classes of Beta-Blockers- A Real-world Retrospective Study in a Tertiary Hospital," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 50(5), pages 42041-42046, June.
    • Handle: RePEc:abf:journl:v:50:y:2023:i:5:p:42041-42046
    DOI: 10.26717/BJSTR.2023.50.008009
    as

    Download full text from publisher

    File URL: https://biomedres.us/pdfs/BJSTR.MS.ID.008009.pdf
    Download Restriction: no
    File URL: https://biomedres.us/fulltexts/BJSTR.MS.ID.008009.php
    Download Restriction: no
    File URL: https://libkey.io/10.26717/BJSTR.2023.50.008009?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:abf:journl:v:50:y:2023:i:5:p:42041-42046. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Angela Roy (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.